SUPERSTRING CAPITAL MANAGEMENT LP
Position in UTHR — UNITED THERAPEUTICS Corp
CIK 1931118
NEW YORK, NY
Position in UTHR
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$3,886,004
+$810,810 QoQ
Shares Held
7,172
+38.3% QoQ
Ownership
0.017%
of shares outstanding
% of Portfolio
2.44%
of 13F equity value
Holder Rank
#278
of 870 holders
Holding Since
Jun 2025
4 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in UTHR Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026SUPERSTRING CAPITAL MANAGEMENT LP holds $5,092,548 across 2 Drug Manufacturers - Specialty & Generic names. UTHR ranks #1 (76.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | UTHR |
UNITED THERAPEUTICS Corp
This page
|
7,172 | $3,886,004 | |
| 2 | KNSA |
Kiniksa Pharmaceuticals International, plc
|
18,867 | $1,206,544 |
All Filings in UTHR
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,886,004 | 7,172 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $3,075,194 | 5,186 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $4,604,999 | 9,451 | Shares | Sole | 2026-02-17 | |
| 2025-06-30 | $1,400,543 | 4,874 | Shares | Sole | 2025-08-14 | |
| No filing history on record for this holder in this stock. | ||||||